Your browser doesn't support javascript.
loading
Zinc transporters as potential therapeutic targets: An updated review.
Hara, Takafumi; Yoshigai, Emi; Ohashi, Takuto; Fukada, Toshiyuki.
Affiliation
  • Hara T; Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima, Japan.
  • Yoshigai E; Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima, Japan.
  • Ohashi T; Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima, Japan.
  • Fukada T; Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima, Japan. Electronic address: fukada@ph.bunri-u.ac.jp.
J Pharmacol Sci ; 148(2): 221-228, 2022 Feb.
Article in En | MEDLINE | ID: mdl-35063137
ABSTRACT
Zinc is an essential trace element that plays important roles in the regulation of various physiological responses in the body. Zinc deficiency is known to cause various health problems, including dysgeusia, skin disorders, and immune disorders. Therefore, the maintenance of healthy zinc content in the body is critical to our healthy life. Zinc homeostasis is tightly controlled by two of the solute carrier protein families SLC30A and SLC39A, called zinc transporters. In the last decade, research on zinc biology has made dramatic progress based on the physiological and functional analysis of zinc transporters in the fields of molecular biology, human genetics, and drug discovery. In particular, since the association between zinc transporters and human diseases was recently reported using human genetics and gene knockout mouse studies, zinc and zinc signals controlled by zinc transporters have been considered useful therapeutic targets. In this review, we introduce the importance of zinc homeostasis based on the findings of zinc transporter functions and their signals in relation to human diseases.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Zinc / Carrier Proteins / Molecular Targeted Therapy Limits: Animals / Humans Language: En Journal: J Pharmacol Sci Journal subject: FARMACOLOGIA Year: 2022 Document type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Zinc / Carrier Proteins / Molecular Targeted Therapy Limits: Animals / Humans Language: En Journal: J Pharmacol Sci Journal subject: FARMACOLOGIA Year: 2022 Document type: Article Affiliation country: Japan